https://openbell.ai/ 2026-10-26T11:31:37.006Z hourly 1.0 https://openbell.ai/support 2026-10-26T11:31:37.006Z monthly 0.7 https://openbell.ai/privacy 2026-10-26T11:31:37.006Z monthly 0.5 https://openbell.ai/terms 2026-10-26T11:31:37.006Z monthly 0.5 https://openbell.ai/feed.json 2026-10-26T11:31:37.006Z hourly 0.8 https://openbell.ai/news/AZN:1793012516000 2026-10-26T11:01:56.000Z daily 0.9 https://cdn.brandfetch.io/AZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud AstraZeneca and HUTCHMED Present Positive Phase III Data for Lung Cancer Combination Therapy AstraZeneca and HUTCHMED presented Phase III data at the ESMO 2026 congress for ORPATHYS (savolitinib) combined with TAGRISSO (osimertinib) in first-line EGFR-mutated non-small cell lung cancer. The results indicated the combination reduced disease progression. The companies jointly developed ORPATHYS, with AstraZeneca responsible for commercialization, highlighting their ongoing oncology collaboration. https://openbell.ai/news/2010:1793012514000 2026-10-26T11:01:54.000Z daily 0.9 https://cdn.brandfetch.io/2010/w/400/h/400?c=1idopYfmtR7ZKg8QMud Saudi Basic Industries Corp. Reports Third-Quarter Financial Results Saudi Basic Industries Corp. (SABIC) reported third-quarter 2026 net profit of 499 million riyals ($133 million), up from 434 million riyals a year earlier, while revenue fell to 28.17 billion riyals from 29.08 billion. Profit growth reflected higher average selling prices and a 1.62 billion-riyal improvement in results from associates and joint ventures, including reversal of an impairment on its Clariant investment. These gains were partly offset by a 916 million-riyal increase in selling and distribution expenses, which SABIC attributed to supply-chain disruptions and shipping tensions around the Strait of Hormuz. https://openbell.ai/news/BMY:1793010716000 2026-10-26T10:31:56.000Z daily 0.9 https://cdn.brandfetch.io/BMY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bristol Myers Squibb and SystImmune Announce Positive Phase 3 Results for Izalontamab Brengitecan in NSCLC Bristol Myers Squibb and SystImmune reported positive interim Phase 3 PANKU-Lung01 results for izalontamab brengitecan in previously treated EGFR-mutated non-small cell lung cancer. The EGFRxHER3 antibody-drug conjugate doubled median progression-free survival compared with chemotherapy. BMS is continuing to develop the drug within its oncology portfolio, citing its potential to address unmet needs across multiple tumor types. https://openbell.ai/news/BA:1793010711000 2026-10-26T10:31:51.000Z daily 0.9 https://cdn.brandfetch.io/BA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Boeing 777 Freighter Production Stalled by Supplier Dispute Boeing’s 777 freighter production has reportedly been halted for two months amid a dispute with a supplier. The stoppage is affecting the company’s commercial airplane manufacturing output and underscores continuing supply-chain challenges in the aerospace sector. The article provides no financial figures or stock-price impact. https://openbell.ai/news/SPCX:1793010703000 2026-10-26T10:31:43.000Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SpaceX Secures $40 Billion in Debt Financing for AI Infrastructure SpaceX secured $40 billion in debt financing to purchase Nvidia GPUs and expand its AI and data center operations, according to reports dated October 26, 2026. CEO Elon Musk confirmed the financing, which the company plans to support alongside revenue from Starlink and launches. The investment is intended to strengthen SpaceX’s AI computing capacity and position it in the growing AI infrastructure market. https://openbell.ai/news/FCM:1793005359000 2026-10-26T09:02:39.000Z daily 0.9 https://cdn.brandfetch.io/FCM/w/400/h/400?c=1idopYfmtR7ZKg8QMud First Class Metals PLC Reports High-Grade Gold Assay Results from Roy Extension First Class Metals PLC reported assay results from the Roy extension, about 1.1 km from historic shafts, confirming a high-grade gold discovery across roughly 300 metres. Eight grab samples exceeded 5 g/t gold, with a peak of 17.3 g/t, and visible gold was identified. The company plans a systematic assessment with a backhoe contractor and aims to mobilize a drill rig to the Pettigrew trend by the end of October 2026; the results may indicate further strike extent along the Roy trend. https://openbell.ai/news/BORR:1793005308000 2026-10-26T09:01:48.000Z daily 0.9 https://cdn.brandfetch.io/BORR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Borr Drilling Provides Update on Prospector 5 Incident Borr Drilling said on October 26 that 110 of the 115 people aboard the Prospector 5 have been safely accounted for following the incident reported the previous day. Search and rescue efforts continue for the five people still missing. The company is working with local authorities and partners to investigate the cause while prioritizing rescue operations and support for those brought ashore. https://openbell.ai/news/6954:1793005294000 2026-10-26T09:01:34.000Z daily 0.9 https://cdn.brandfetch.io/6954/w/400/h/400?c=1idopYfmtR7ZKg8QMud FANUC Corporation Raises Full-Year Sales and Profit Forecasts FANUC Corporation raised its sales and profit forecasts for the current fiscal year, citing a more positive financial outlook. Its shares rose 0.9% amid broader market activity in Tokyo. The article did not provide revised forecast figures. https://openbell.ai/news/SPSN:1793003500000 2026-10-26T08:31:40.000Z daily 0.9 https://cdn.brandfetch.io/SPSN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Swiss Prime Site Announces New Mid-Term Targets, Raised Guidance, and Full Acquisition of FlexOffice Swiss Prime Site set 2030 targets of more than CHF 530 million in rental income, over CHF 130 million in asset management fee income, and assets under management exceeding CHF 23 billion. It raised its 2026 FFO I per-share guidance to CHF 4.30–4.35 from CHF 4.25–4.30 and improved its outlook for vacancy rates and asset growth. SPS also agreed to acquire the remaining shares of furnished-office provider FlexOffice, in which it already owns 33%; the deal is expected to close in Q4 2026 and add about CHF 10 million in earnings in 2027. https://openbell.ai/news/PRCO.B:1793001834000 2026-10-26T08:03:54.000Z daily 0.9 https://cdn.brandfetch.io/PRCO.B/w/400/h/400?c=1idopYfmtR7ZKg8QMud Precio Fishbone Divests Holding in Omnia to Monterro Precio Fishbone agreed to sell its holding in Omnia to private equity firm Monterro for SEK 83 million. The article describes the divestment as a strategic move but provides no further details on the stake size or market impact. https://openbell.ai/news/SPAGO:1793001805000 2026-10-26T08:03:25.000Z daily 0.9 https://cdn.brandfetch.io/SPAGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Spago Nanomedical Announces Move to Go Private Spago Nanomedical announced on October 24, 2026, that it intends to move from public to private status. The clinical-stage nanomedicine company described the move as a change to its corporate structure and public-market presence; the report provided no financial terms or stock-price impact.